Spots Global Cancer Trial Database for Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
Official Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
Study ID: NCT05218096
Study Description
Brief Summary: This study will evaluate the efficacy and safety of ALXN2050 (120 milligrams \[mg\], 180 mg) in participants with generalized myasthenia gravis (gMG). Safety will be monitored throughout the study.
Detailed Description: The study consists of a blinded 8-week Primary Evaluation Period (PEP) and a blinded 26-week Extended Treatment Period (ETP). After completion of 34 weeks of treatment, participants will enter an Open-label Extension (OLE) Period for up to 1.5 years.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Phoenix, Arizona, United States
Research Site, Aurora, Colorado, United States
Research Site, Boca Raton, Florida, United States
Research Site, Port Charlotte, Florida, United States
Research Site, Tampa, Florida, United States
Research Site, Lexington, Kentucky, United States
Research Site, New Hyde Park, New York, United States
Research Site, Chapel Hill, North Carolina, United States
Research Site, Charlotte, North Carolina, United States
Research Site, West Chester, Ohio, United States
Research Site, Portland, Oregon, United States
Research Site, Springfield, Oregon, United States
Research Site, Philadelphia, Pennsylvania, United States
Research Site, Nashville, Tennessee, United States
Research Site, Houston, Texas, United States
Research Site, San Antonio, Texas, United States
Research Site, Milwaukee, Wisconsin, United States
Research Site, Edmonton, Alberta, Canada
Research Site, London, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Berlin, , Germany
Research Site, Bochum, , Germany
Research Site, Düsseldorf, , Germany
Research Site, Hamburg, , Germany
Research Site, Leipzig, , Germany
Research Site, Bergamo, , Italy
Research Site, Milano, , Italy
Research Site, Napoli, , Italy
Research Site, Pisa, , Italy
Research Site, Roma, , Italy
Research Site, Rome, , Italy
Research Site, Udine, , Italy
Research Site, Daegu, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Yangsan-si, , Korea, Republic of
Research Site, Belgrade, , Serbia
Research Site, Nis, , Serbia
Research Site, Barcelona, , Spain
Research Site, Madrid, , Spain
Research Site, Malaga, , Spain
Research Site, Murcia, , Spain
Research Site, Sevilla, , Spain
Research Site, Hualien City, , Taiwan
Research Site, Taipei, , Taiwan
Research Site, Taoyuan City, , Taiwan
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
